BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38917419)

  • 1. Exploiting the Unique Biology of
    Itkin T; Unger K; Barak Y; Yovel A; Stekolshchik L; Ego L; Aydinov Y; Gerchman Y; Sapir A
    Astrobiology; 2024 Jun; 24(6):579-589. PubMed ID: 38917419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An apparent core/shell architecture of polyQ aggregates in the aging Caenorhabditis elegans neuron.
    Fisher RS; Jimenez RM; Soto E; Kalev D; Elbaum-Garfinkle S
    Protein Sci; 2021 Jul; 30(7):1482-1486. PubMed ID: 33966305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy genes protect against disease caused by polyglutamine expansion proteins in Caenorhabditis elegans.
    Jia K; Hart AC; Levine B
    Autophagy; 2007; 3(1):21-5. PubMed ID: 17172799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Muscle Experiment: Hardware and Operational Lessons for Future Astrobiology Space Experiments.
    Pollard AK; Gaffney CJ; Deane CS; Balsamo M; Cooke M; Ellwood RA; Hewitt JE; Mierzwa BE; Mariani A; Vanapalli SA; Etheridge T; Szewczyk NJ
    Astrobiology; 2020 Aug; 20(8):935-943. PubMed ID: 32267726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity of copper and zinc alone and in combination in Caenorhabditis elegans model of Huntington's disease and protective effects of rutin.
    Cordeiro LM; Soares MV; da Silva AF; Dos Santos LV; de Souza LI; da Silveira TL; Baptista FBO; de Oliveira GV; Pappis C; Dressler VL; Arantes LP; Zheng F; Soares FAA
    Neurotoxicology; 2023 Jul; 97():120-132. PubMed ID: 37302585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diphenyl diselenide protects a Caenorhabditis elegans model for Huntington's disease by activation of the antioxidant pathway and a decrease in protein aggregation.
    Bicca Obetine Baptista F; Arantes LP; Machado ML; da Silva AF; Marafiga Cordeiro L; da Silveira TL; Soares FAA
    Metallomics; 2020 Jul; 12(7):1142-1158. PubMed ID: 32453327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing polyglutamine tract aggregation in the nematode Caenorhabditis elegans.
    Sotiriou A; Ploumi C; Charmpilas N; Tavernarakis N
    Methods Cell Biol; 2024; 181():1-15. PubMed ID: 38302233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Fluids Mixing Enclosure System for Life Science Experiments During a Commercial
    Warren P; Golden A; Hanover J; Love D; Shephard F; Szewczyk NJ
    Adv Space Res; 2013 Jun; 51(12):2241-2250. PubMed ID: 23794777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strengths and limitations of morphological and behavioral analyses in detecting dopaminergic deficiency in Caenorhabditis elegans.
    Smith LL; Ryde IT; Hartman JH; Romersi RF; Markovich Z; Meyer JN
    Neurotoxicology; 2019 Sep; 74():209-220. PubMed ID: 31323240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model.
    Van Assche R; Borghgraef C; Vaneyck J; Dumoulin M; Schoofs L; Temmerman L
    J Negat Results Biomed; 2017 Aug; 16(1):14. PubMed ID: 28830560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel hydroxylamine derivative NG-094 suppresses polyglutamine protein toxicity in Caenorhabditis elegans.
    Haldimann P; Muriset M; Vígh L; Goloubinoff P
    J Biol Chem; 2011 May; 286(21):18784-94. PubMed ID: 21471208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stress of misfolded proteins: C. elegans models for neurodegenerative disease and aging.
    Brignull HR; Morley JF; Morimoto RI
    Adv Exp Med Biol; 2007; 594():167-89. PubMed ID: 17205684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of
    Liang JJH; McKinnon IA; Rankin CH
    J Neurogenet; 2020; 34(3-4):527-548. PubMed ID: 32772603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans.
    Morley JF; Brignull HR; Weyers JJ; Morimoto RI
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10417-22. PubMed ID: 12122205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of RNAi in Caenorhabditis elegans is maintained during spaceflight.
    Etheridge T; Nemoto K; Hashizume T; Mori C; Sugimoto T; Suzuki H; Fukui K; Yamazaki T; Higashibata A; Szewczyk NJ; Higashitani A
    PLoS One; 2011; 6(6):e20459. PubMed ID: 21673804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling neurodegenerative diseases in Caenorhabditis elegans.
    Li J; Le W
    Exp Neurol; 2013 Dec; 250():94-103. PubMed ID: 24095843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteins in aggregates functionally impact multiple neurodegenerative disease models by forming proteasome-blocking complexes.
    Ayyadevara S; Balasubramaniam M; Gao Y; Yu LR; Alla R; Shmookler Reis R
    Aging Cell; 2015 Feb; 14(1):35-48. PubMed ID: 25510159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Transparent Window into Biology: A Primer on Caenorhabditis elegans.
    Corsi AK; Wightman B; Chalfie M
    Genetics; 2015 Jun; 200(2):387-407. PubMed ID: 26088431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans.
    Wang YA; Kammenga JE; Harvey SC
    Hum Genomics; 2017 May; 11(1):12. PubMed ID: 28545550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of rutin on ASH neurons in
    Cordeiro LM; Soares MV; da Silva AF; Machado ML; Bicca Obetine Baptista F; da Silveira TL; Arantes LP; Soares FAA
    Nutr Neurosci; 2022 Nov; 25(11):2288-2301. PubMed ID: 34311678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.